View Archive »
About The Cover
Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model. See Duquette et al.
|
|
Table of Contents
Editorial: Immunology
|
| How lung infection leads to gut injury |
|
https://doi.org/10.18632/oncotarget.6470
|
| 42394-42395 |
Priority Research Papers
|
| Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.6377
|
| 42396-42410 |
|
| Novel and potent antitumor and antimetastatic di2pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents |
|
https://doi.org/10.18632/oncotarget.6389
|
| 42411-42428 |
|
| Genomic landscape of liposarcoma |
|
https://doi.org/10.18632/oncotarget.6464
|
| 42429-42444 |
|
| Metastasisassociated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patientderived papillary thyroid carcinoma preclinical model |
|
https://doi.org/10.18632/oncotarget.6442
|
| 42445-42467 |
|
| Longer genotypicallyestimated leukocyte telomere length is associated with increased adult glioma risk |
|
https://doi.org/10.18632/oncotarget.6468
|
| 42468-42477 |
|
| Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NFκB |
|
https://doi.org/10.18632/oncotarget.6478
|
| 42478-42490 |
Research Papers: Pathology
|
| Aberrant modulation of the BRCA1 and G1/S cell cycle pathways in alcoholic hepatitis patients with Mallory Denk Bodies revealed by RNA sequencing |
|
https://doi.org/10.18632/oncotarget.6382
|
| 42491-42503 |
|
| Genomewide haplotype association study identify TNFRSF1A CASP7 LRP1B CDH1 and TG genes associated with Alzheimer’s disease in Caribbean Hispanic individuals |
|
https://doi.org/10.18632/oncotarget.6391
|
| 42504-42514 |
|
| Antihypertensive treatments in adult autosomal dominant polycystic kidney disease: network metaanalysis of the randomized controlled trials |
|
https://doi.org/10.18632/oncotarget.6452
|
| 42515-42529 |
|
| Oleoylethanolamide an endogenous PPARα ligand attenuates liver fibrosis targeting hepatic stellate cells |
|
https://doi.org/10.18632/oncotarget.6466
|
| 42530-42540 |
Research Papers: Immunology
|
| Saikosaponin A inhibits influenza A virus replication and lung immunopathology |
|
https://doi.org/10.18632/oncotarget.6448
|
| 42541-42556 |
|
| Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis |
|
https://doi.org/10.18632/oncotarget.6449
|
| 42557-42568 |
|
| NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance |
|
https://doi.org/10.18632/oncotarget.5559
|
| 42569-42574 |
Research Papers: Chromosome
|
| Hormone stimulation of androgen receptor mediates dynamic changes in DNA methylation patterns at regulatory elements |
|
https://doi.org/10.18632/oncotarget.6471
|
| 42575-42589 |
Reviews
|
| The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications |
|
https://doi.org/10.18632/oncotarget.6052
|
| 42590-42602 |
|
| The double face of Morgana in tumorigenesis |
|
https://doi.org/10.18632/oncotarget.6058
|
| 42603-42612 |
|
| Noncoding RNAs in cardiac regeneration |
|
https://doi.org/10.18632/oncotarget.6073
|
| 42613-42622 |
Research Papers
|
| Diagnosis of skin cancer by correlation and complexity analyses of damaged DNA |
|
https://doi.org/10.18632/oncotarget.6003
|
| 42623-42631 |
|
| AcylCoA synthetase4 a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptorpositive and negative breast cancer |
|
https://doi.org/10.18632/oncotarget.5822
|
| 42632-42650 |
|
| EMTinduced metabolite signature identifies poor clinical outcome |
|
https://doi.org/10.18632/oncotarget.4765
|
| 42651-42660 |
|
| Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese population |
|
https://doi.org/10.18632/oncotarget.6124
|
| 42661-42666 |
|
| The Akt1/IL6/STAT3 pathway regulates growth of lung tumor initiating cells |
|
https://doi.org/10.18632/oncotarget.5626
|
| 42667-42686 |
|
| ILs3 6 and 11 increase but ILs10 and 24 decrease stemness of human prostate cancer cells in vitro |
|
https://doi.org/10.18632/oncotarget.5883
|
| 42687-42703 |
|
| Grifolin directly targets ERK1/2 to epigenetically suppress cancer cell metastasis |
|
https://doi.org/10.18632/oncotarget.5678
|
| 42704-42716 |
|
| NFκB drives acquired resistance to a novel mutantselective EGFR inhibitor |
|
https://doi.org/10.18632/oncotarget.3956
|
| 42717-42732 |
|
| Identification of a novel platelet antagonist that binds to CLEC2 and suppresses podoplanininduced platelet aggregation and cancer metastasis |
|
https://doi.org/10.18632/oncotarget.5811
|
| 42733-42748 |
|
| Colon cancer cell invasion is promoted by protein kinase CK2 through increase of endothelinconverting enzyme1c protein stability |
|
https://doi.org/10.18632/oncotarget.5722
|
| 42749-42760 |
|
| MiR5425p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1 |
|
https://doi.org/10.18632/oncotarget.6199
|
| 42761-42772 |
|
| Predictive significance of DNA damage and repair biomarkers in triplenegative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis |
|
https://doi.org/10.18632/oncotarget.6001
|
| 42773-42780 |
|
| A functional variant in miR155 regulation region contributes to lung cancer risk and survival |
|
https://doi.org/10.18632/oncotarget.5840
|
| 42781-42792 |
|
| Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.6000
|
| 42793-42802 |
|
| Iron deficient erythropoiesis might play key role in development of anemia in cancer patients |
|
https://doi.org/10.18632/oncotarget.5658
|
| 42803-42812 |
|
| LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway |
|
https://doi.org/10.18632/oncotarget.5970
|
| 42813-42824 |
|
| Bone marrowderived mesenchymal stem cellsecreted IL8 promotes the angiogenesis and growth of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.5739
|
| 42825-42837 |
|
| HOXB9 induction of mesenchymaltoepithelial transition in gastric carcinoma is negatively regulated by its hexapeptide motif |
|
https://doi.org/10.18632/oncotarget.5814
|
| 42838-42853 |
|
| HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF1R degradation |
|
https://doi.org/10.18632/oncotarget.5733
|
| 42854-42867 |
|
| HER3 overexpression and overall survival in gastrointestinal cancers |
|
https://doi.org/10.18632/oncotarget.5998
|
| 42868-42878 |
|
| Enhancement of NAD+dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogentreated mammary epithelial cells |
|
https://doi.org/10.18632/oncotarget.6002
|
| 42879-42891 |
|
| Involvement of MBD4 inactivation in mismatch repairdeficient tumorigenesis |
|
https://doi.org/10.18632/oncotarget.5740
|
| 42892-42904 |
|
| Growthstimulatory activity of TIMP2 is mediated through cSrc activation followed by activation of FAK PI3kinase/AKT and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells |
|
https://doi.org/10.18632/oncotarget.5466
|
| 42905-42922 |
|
| Therapeutics targeting CD90integrinAMPKCD133 signal axis in liver cancer |
|
https://doi.org/10.18632/oncotarget.5976
|
| 42923-42937 |
|
| Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NKcell clonality |
|
https://doi.org/10.18632/oncotarget.5480
|
| 42938-42951 |
|
| Hepatitis B virus HBV receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk |
|
https://doi.org/10.18632/oncotarget.5518
|
| 42952-42962 |
|
| Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2 |
|
https://doi.org/10.18632/oncotarget.5981
|
| 42963-42975 |
|
| Cancer metastasis and EGFR signaling is suppressed by amiodaroneinduced versican V2 |
|
https://doi.org/10.18632/oncotarget.5621
|
| 42976-42987 |
|
| Statin use and breast cancer survival and risk: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.5557
|
| 42988-43004 |
|
| TGFβ blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner |
|
https://doi.org/10.18632/oncotarget.5656
|
| 43005-43015 |
|
| Inhibition of the Tcf/betacatenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis |
|
https://doi.org/10.18632/oncotarget.5513
|
| 43016-43032 |
|
| miR150 inhibits terminal erythroid proliferation and differentiation |
|
https://doi.org/10.18632/oncotarget.5824
|
| 43033-43047 |
|
| Stromal cellmediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.5528
|
| 43048-43064 |
|
| Mitochondrial oncobioenergetic index: A potential biomarker to predict progression from indolent to aggressive prostate cancer |
|
https://doi.org/10.18632/oncotarget.5487
|
| 43065-43080 |
|
| Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor AR/MMP13 signals |
|
https://doi.org/10.18632/oncotarget.5638
|
| 43081-43089 |
Clinical Research Papers
|
| Aspartate aminotransferaselymphocyte ratio index and systemic immuneinflammation index predict overall survival in HBVrelated hepatocellular carcinoma patients after transcatheter arterial chemoembolization |
|
https://doi.org/10.18632/oncotarget.5719
|
| 43090-43098 |
|
| Dietary fat and fatty acid intake and epithelial ovarian cancer risk: evidence from epidemiological studies |
|
https://doi.org/10.18632/oncotarget.5525
|
| 43099-43119 |
|
| Clinical analysis of intraoperative radiotherapy during breastconserving surgery of early breast cancer in the Chinese Han population |
|
https://doi.org/10.18632/oncotarget.5716
|
| 43120-43126 |
|
| Phase 1b study of lenvatinib E7080 in combination with temozolomide for treatment of advanced melanoma |
|
https://doi.org/10.18632/oncotarget.5756
|
| 43127-43134 |
|
| Chemotherapy of metastatic triple negative breast cancer: Experience of using platinumbased chemotherapy |
|
https://doi.org/10.18632/oncotarget.5654
|
| 43135-43143 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
